Ketamine Hydrochloride
NMCCL.2018.0011
Phase 3 small_molecule terminated
Quick answer
Ketamine Hydrochloride for Suicide is a Phase 3 program (small_molecule) at Camp4 Therapeutics Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Camp4 Therapeutics Corp
- Indication
- Suicide
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated